"For every dollar we spend on a data initiative, we are able to get 40$ in return "
Andy McPhee, Science and Enabling Units Data & Analytics Engineering Lead, AstraZeneca
Within 3 mins
90% of data ready for analysis
From 15 days down to 3 hours
Planning cycle time
$1BN a year savings
Shaving just 1 month off of every one of clinical trials

Pushing the boundaries of data to deliver life-changing medicines

AstraZeneca is a global, science-led biopharmaceutical business. The focus areas are cardiovascular and metabolic diseases; oncology; respiratory, inflammation and autoimmunity; infection and neuroscience. There is a fine balance between speed, in terms of how you develop and get drugs into a commercial state and trust: If there is no quality in the data, drugs will not get into a commercial state and can affect the life of patients. Innovation is driven by data. AstraZeneca has built a data lake on AWS and Talend is at the heart of that architecture, growing 5 times the amount it was when AstraZeneca started its data journey.

The focus of Talend has been around the Enabling Units, the global product portfolio strategy and the medical functions. AstraZeneca is now expanding and exploiting the usage of Talend across commercial functions and the science unit: How to think about creating a drug from scratch, utilizing ground-breaking tools like genomic sequencing to understand the effect of a drug will have on a human being. And then, going to the rigor of testing, shortening the time of clinical trials. Shaving just 1 month off of every one of clinical trials will save AstraZeneca $1BN a year.